TNM Trial: Upfront Docetaxel [T] and Alternating iv and Oral Vinorelbine [N] Followed, by Either Maintenance Oral Vinorelbine, or Observation for Advanced Breast Cancer

Trial Profile

TNM Trial: Upfront Docetaxel [T] and Alternating iv and Oral Vinorelbine [N] Followed, by Either Maintenance Oral Vinorelbine, or Observation for Advanced Breast Cancer

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Vinorelbine (Primary) ; Vinorelbine (Primary) ; Docetaxel
  • Indications Breast cancer
  • Focus Therapeutic Use
  • Acronyms TNM Trial
  • Most Recent Events

    • 07 Feb 2017 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 07 Feb 2017 Planned primary completion date changed from 1 Jun 2016 to 1 Jun 2017.
    • 07 Feb 2017 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top